Shock, grief and the challenge of healing: Israel’s health system responds to the October attacks
Dr Michel Thieren, WHO Special Representative in Israel, spent almost 2 weeks travelling across the country to see how the health system is responding in the aftermath of the attacks led by Hamas on 7 October. This is his account of what he saw and heard. Note: Some readers may find the content of this […]
Roche’s Alecensa reduces the risk of disease recurrence or death by an unprecedented 76% in people with ALK-positive early-stage non-small cell lung cancer
These Phase III data are the first and only to show an improvement in disease-free survival in early-stage resected ALK-positive non-small cell lung cancer (NSCLC) With about one in two people with early-stage NSCLC experiencing disease recurrence following surgery, despite adjuvant chemotherapy,1 more effective treatment options are urgently needed to provide the best chance for […]
Roche IL-6 is the first immunoassay approved to aid sepsis diagnosis in newborns
Neonatal sepsis is a leading cause of death for newborns Testing IL-6 can indicate a neonatal sepsis infection earlier than other biomarkers Earlier diagnosis of neonatal sepsis can lead to improved outcomes and a reduction of long-term complications from sepsis Basel, 18 October 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the […]
UNICEF and WHO warn that further attacks and disruptions of health and nutrition services in Sudan could cost over 10 000 young lives by the end of 2023
6 months of conflict in Sudan leave millions of children at risk of cholera, dengue, measles, malaria and other diseases without sufficient containment capacities 18 October 2023, Port Sudan, Sudan – Since the outbreak of the conflict in Sudan on 15 April 2023, UNICEF, WHO and partners have been supporting the Federal Ministry of Health […]
Union Health Secretary Shri Sudhansh Pant delivers keynote address at National Conclave on “Augmented Zoonotic Diseases Surveillance at Human – Wildlife Interface” & National Conclave for Endorsement of “National Action Plan for Prevention and Control of Snakebite Envenoming” to Stakeholders
“Zoonotic disease is one of the areas of concern which is affecting the humans as well as the animal health. 75% of newly emerging infectious diseases that have affected people over last three decades are zoonotic in nature. The limited knowledge and skill to identify zoonotic diseases, coupled with limited diagnostic facilities at all levels […]
Roche’s OCREVUS twice-yearly, 10-minute subcutaneous injection was non-inferior to intravenous infusion and provided near-complete suppression of brain lesions
Late-breaking Phase III results show subcutaneous injection was non-inferior to intravenous infusion based on OCREVUS levels in the blood over 12 weeks OCREVUS subcutaneous injection was comparable to IV infusion in providing rapid and sustained depletion of B cells and near-complete suppression of MRI lesion activity in the brain over 24 weeks The safety profile […]
Lifesaving WHO health supplies land in Egypt for people-in-need in Gaza
A plane carrying 78 cubic metres of health supplies from WHO’s logistics hub in Dubai has landed in Al-Arish airport in Egypt. The supplies will be delivered to Gaza to meet critical health needs as soon as humanitarian access through the Rafah crossing is established. Every hour these supplies remain on the Egyptian side of […]
Lifesaving WHO health supplies land in Egypt for people-in-need in Gaza
A plane carrying 78 cubic metres of health supplies from WHO’s logistics hub in Dubai has landed in Al-Arish airport in Egypt. The supplies will be delivered to Gaza to meet critical health needs as soon as humanitarian access through the Rafah crossing is established. Every hour these supplies remain on the Egyptian side of […]
Late-breaking data for Roche’s BTK inhibitor fenebrutinib show brain penetration and significant reduction in lesions in patients with relapsing multiple sclerosis
New data from Phase II FENopta study in relapsing multiple sclerosis (RMS) show fenebrutinib crosses the blood-brain barrier with the potential to act directly on the chronic inflammation related to multiple sclerosis (MS) More than 90% relative reduction in new/enlarging T2 lesions and new T1 gadolinium-enhancing (Gd+) lesions with fenebrutinib beginning at 8 weeks The […]
New funding to ensure 370 million children receive polio vaccinations and to boost health innovation in low-income countries
11 October 2023: Brussels, Belgium: Today, the European Commission, the European Investment Bank and the Bill & Melinda Gates Foundation announced a new financing partnership to address critical global health opportunities: eradicating polio and ensuring that innovations in health are more accessible to the people who need them most. The World Health Organization and UNICEF, […]
